Latest leukemia Stories
Would Become First EMA-approved Therapy for Patients in Europe SUNNYVALE, Calif., May 22, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
WESTON, Fla., May 18, 2015 /PRNewswire/ -- Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications
Data to be Featured in Oral Presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting MENLO PARK, Calif., May 14, 2015 /PRNewswire/ -- Asterias Biotherapeutics,
IMBRUVICA Combination Data in Chronic Lymphocytic Leukemia to be Featured in Official ASCO Press Program SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
- Note: This release corresponds to ASCO abstracts LBA8512, 8587, 8590, TPS8609, TPS8608, LBA7005, 7012, TPS8599, TPS8601, 7024, TPS7095, TPS7096, 5005, 5047, 5053, 5014, 5028, TPS5071, TPS5084, 10503,
Trial studies breakthrough method for turning patients' immune system against their cancer cells BOSTON, May 11, 2015 /PRNewswire-USNewswire/ --
-- AbbVie plans to submit regulatory applications for venetoclax to the U.S.
Genomic service detects 30 gene mutations to aid in the diagnosis, prognosis, monitoring and treatment selection for several myeloid neoplasms MADISON, N.J., May 4, 2015 /PRNewswire/
SUNNYVALE, Calif., May 1, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
Clinical Leukemia is a peer-reviewed medical journal published by CIG Media Group. The journal publishes articles on detection, diagnosis, prevention, and treatment of leukemia. The main emphasis is on recent scientific developments in all areas related to leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance, gene and antisense therapy; pathology, markers, and prognostic indicators, chemoprevention strategies,...
- A woman chauffeur.
- A woman who operates an automobile.